HK1151733A1 - Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same - Google Patents

Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same

Info

Publication number
HK1151733A1
HK1151733A1 HK11105932.7A HK11105932A HK1151733A1 HK 1151733 A1 HK1151733 A1 HK 1151733A1 HK 11105932 A HK11105932 A HK 11105932A HK 1151733 A1 HK1151733 A1 HK 1151733A1
Authority
HK
Hong Kong
Prior art keywords
antigen
same
synthetic peptide
mucosal vaccine
drug vehicle
Prior art date
Application number
HK11105932.7A
Other languages
English (en)
Inventor
Hiroshi Kido
Tsunetomo Takei
Dai Mizuno
Original Assignee
Univ Tokushima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tokushima filed Critical Univ Tokushima
Publication of HK1151733A1 publication Critical patent/HK1151733A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11105932.7A 2008-04-02 2011-06-13 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same HK1151733A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008096244 2008-04-02
PCT/JP2009/056508 WO2009123119A1 (ja) 2008-04-02 2009-03-30 合成ペプチドを含有する抗原薬物ビークルとこれを用いる粘膜ワクチン

Publications (1)

Publication Number Publication Date
HK1151733A1 true HK1151733A1 (en) 2012-02-10

Family

ID=41135493

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11105932.7A HK1151733A1 (en) 2008-04-02 2011-06-13 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same

Country Status (8)

Country Link
US (1) US8287887B2 (zh)
EP (1) EP2281574B1 (zh)
JP (1) JP5473899B2 (zh)
KR (1) KR101614344B1 (zh)
CN (1) CN101980721B (zh)
CA (1) CA2720277C (zh)
HK (1) HK1151733A1 (zh)
WO (1) WO2009123119A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103002908B (zh) * 2010-03-02 2015-09-02 国立大学法人德岛大学 粘膜疫苗
WO2013031827A1 (ja) 2011-08-29 2013-03-07 国立大学法人徳島大学 Rsv粘膜ワクチン
EP3845242A4 (en) 2018-08-30 2022-05-11 Tokushima University IMMUNE TOLERANCE INDUCING AGENT AND THERAPEUTIC OR PROPHYLACTIC AGENT FOR AN ALLERGIC DISORDER
JPWO2022168889A1 (zh) * 2021-02-03 2022-08-11

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6244011A (ja) 1985-08-22 1987-02-26 古河電気工業株式会社 押出型モ−ルドジヨイントの補強絶縁部成形方法
SK71496A3 (en) 1993-12-08 1996-11-06 Tokyo Tanabe Co Synthetic peptides, preparation method thereof, pharmaceutical composition containing them and its use
AU3844201A (en) 2000-02-16 2001-08-27 Univ Northwestern Polypeptoid pulmonary surfactants
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
ITMI20021058A1 (it) 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
JP2004305006A (ja) 2003-04-01 2004-11-04 Japan Science & Technology Agency 人工調製肺サーファクタント
US7611863B2 (en) * 2004-01-08 2009-11-03 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Selective staining of biomembranes using voltage-sensitive dyes
CA2579710C (en) 2004-04-05 2013-01-08 The University Of Tokushima Antigen-drug vehicle enabling transmucosal and transdermal administration, and method of inducing mucosal immunity and mucosal vaccine and dds using the same
EP1930025B1 (en) 2005-08-05 2013-05-01 The University of Tokushima ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE

Also Published As

Publication number Publication date
US8287887B2 (en) 2012-10-16
KR101614344B1 (ko) 2016-04-21
WO2009123119A1 (ja) 2009-10-08
KR20110002841A (ko) 2011-01-10
CN101980721A (zh) 2011-02-23
CN101980721B (zh) 2013-03-13
CA2720277C (en) 2017-01-17
EP2281574B1 (en) 2014-07-09
EP2281574A1 (en) 2011-02-09
CA2720277A1 (en) 2009-10-08
JPWO2009123119A1 (ja) 2011-07-28
US20110110971A1 (en) 2011-05-12
EP2281574A4 (en) 2011-03-23
JP5473899B2 (ja) 2014-04-16

Similar Documents

Publication Publication Date Title
EP2326718A4 (en) INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THEM
IL219048A (en) Peptide compounds derived from urcl10
IL220752A0 (en) Tem8 peptides and vaccines comprising the same
IL232394A (en) A peptide, its uses and a kit containing it
EP2275440A4 (en) GROWTH FACTOR IMITING PEPTIDES AND THEIR USE
IL209967A0 (en) Cdca1 epitope peptides and vaccines containing the same
HK1157204A1 (zh) 表位肽及包含它們的疫苗
IL209870A0 (en) Mybl2 epitope peptides and vaccines containing the same
IL214130A0 (en) Neil3 peptides and vaccines including the same
IL213026A0 (en) TNA-a INHIBITING PEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
HK1151733A1 (en) Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
HK1157397A1 (zh) 表位肽及包含它的疫苗
GB0818065D0 (en) Immunogenic peptides and uses thereof
EP2285827A4 (en) PEPTIDES AND ITS USE
EP2358740A4 (en) CYCLIC PEPTIDES AND USES THEREOF
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
ZA201104890B (en) Wdrpuh epitope peptides and vaccines containing the same
IL207174A0 (en) Peptides, compositions, and uses thereof
IL219927A0 (en) Mybl2 peptides and vaccines containing the same
GB0823492D0 (en) Antigenic peptides and uses thereof
GB0816561D0 (en) Peptides and uses thereof
GB0800502D0 (en) Peptides and their uses